Author Archives: nev001

Fedmedagen 2014

The Obesity Day (Fedmedagen) is an interdisciplinary seminar for all who do research on obesity and metabolic diseases. This year it will be held on October 2. Program and information will be given on a later date.

Do you wish to hold a presentation? Deadline for sending in abstracts is June 15.
Registration before July 1.
Registration and abstract should be sent to Christine Haugen.
The seminar is free of charge, and lunch will be served to those who have registered.

Have you started developing e-learning?

Eva GerdtsThere is a need to implement new, student-activating teaching and learning methods. The medical faculties are collaborating on a national platform for e-learning resources (in Norwegian). It is important that we here at K2 contribute so that this website becomes a good e-learning resource for our students. There is much pre-made content already available online for medical examination techniques and methods. In order to get ideas, you may, for instance, see Oxford Medical Education or Geeky Medics or Youtube. Several producers of web content have granted MOF permission to reuse their material. Have you found something which may be used in your student teaching, and wish to have this dubbed in Norwegian language or have comments added? You may then contact Eirik Dalheim who will clarify copyright issues and other formalities. Eirik will also assist you in adjusting the contents to your needs. Remember that all course changes must be approved by the person in charge of the course.

Good luck!

Eva

COST – New researcher network for biomedical and health research

logo_cost

COST is a European network organisation of which most of the countries in Europe (including Norway and all the EU-nations) are members. An important task for COST is to improve European research cooperation by initiating scientific networks (called “COST-actions”).

General information about COST you can find here (in Norwegian) and here.
Summaries about the COST-actions you can find here.

The Norwegian Research Council is coordinating the process concerning the Norwegian participation in COST-actions. If you are interested send this form to Hans Hellebostad.

Public defence week 24

bruun_mikalsenIngvild Bruun Mikalsen will have her public defence on Friday June 13, 2014.
Trial lecture: Friday June 13, 2014, 09:15
Topic: «Design og gjennomføring av anerkjente multisenterstudier i barnepopulasjoner – styrker og svakheter»
Public defence: Friday June 13, 2014, 10:30
Place: Aula 2nd floor, South Building, Stavanger University Hospital
Title of dissertation: «Asthma, atopy and lung function at 11 years of age after bronchiolitis in infancy»
1st opponent: Professor Søren Pedersen, Syddansk Universitet, Odense
2nd opponent:
Professor Britt Nakstad, Universitetet i Oslo
Poster and press release (both in Norwegian)

International TB vaccine symposium

The International Symposium “A new horizon for preventative vaccines against tuberculosis” was arranged in Madrid, May 7-8, and was opened by Her Majesty Queen Sofia of Spain. The symposium was organised by TuBerculosis Vaccine Initiative (TBVI), in cooperation with the University of Zaragoza and Fundación Ramón Areces.

Professor Harleen Grewal, was invited to speak on the key results linked to the development of a TB clinical trial site in Southern India, led by the TB Trials consortium, and met the Queen in person.

Harleen and the Queen

Public defence week 23

Marianne Øksnes will have her public defence on Friday June 6, 2014.
Trial lecture: Friday June 6, 2014, 10:30
Topic: «Metabolic syndrome and adrenal diseases»
Public defence: Friday June 6, 2014, 12:15
Place: Auditorium 1, BB-building, Jonas Lies vei 91
Title of dissertation: «Glucocorticoid treatment and quality of life in Adison’s disease»
1st opponent: Professor Susan Webb, Autonomous University, Barcelona, Spain
2nd opponent:
Professor Marcus Quinkler, Charité Universitätsmedizin Berlin
Poster (in Norwegian)

Seminar – Perspectives in Translational Medicine

Wednesday next week there will be a new seminar in the common seminar series for K1 and K2.

Title: “Molecular classification of gynecological cancers – progress and challenges for individualizing treatment strategies”
Presenter: Helga B. Salvesen, Chief Physician and Professor at the Women’s Clinic
Time and place: Wednesday May 4, 14.15-15.00, Store Auditorium, Central Building.
Chair: Anders Molven

Tea/coffee will be served

Mandatory duty work for UiB PhD-Candidates

Roland JonssonAs is known, all PhD-candidates funded by the University have a four-year employment contract, where 25 % of the employment is allocated mandatory duty work. This work has to be planned each year in collaboration with supervisor(s) and employer. The faculty’s and the institutes’ executive officers for research education have reviewed this practice. It turns out that the amount of work time spent on duty work differs a lot between the PhD-candidates.  Currently, almost 50 PhD-candidates at K2 are UiB-funded, and when considering the fact that each of these PhD-candidates in theory should spend one whole year on duty work, we are talking about nearly 50 man-years available at the department’s disposal. Thus we should aim for a good structure in the organization of duty work so that this resource is utilized optimally.

Examples of actions discussed:

  • All UiB-funded candidates and their supervisors must inform executive officer for research education about planned duty work ahead of each year.
  • All scientific employees may, in addition, ahead of each semester submit tasks they wish to recruit PhD-candidates for, but where they have not yet obtained any.  This includes teaching tasks, communications work, conference/seminar organization, database work, supervision of Master students, etc.
  • All new UiB-funded PhD-candidates will, together with their principal supervisor, be called inn for a short meeting regarding planning of duty work with executive officer for research education and head of research as soon as application for admission to the PhD-programme has been submitted.

Roland